Q1 2026 Entero Healthcare Solutions Ltd Earnings Call Transcript
Key Points
- Entero Healthcare Solutions Ltd (NSE:ENTERO) reported a strong start to the financial year with Q1 revenues growing 28% year-on-year, significantly outpacing the industry growth rate of 9%.
- The company achieved a gross profit increase of 40% year-on-year, with gross margins improving by 83 basis points to 9.9%, driven by higher value-added services and procurement efficiencies.
- EBITDA for the quarter grew by 66% year-on-year, with margins improving by 82 basis points to 3.6%, showcasing strong operational performance.
- Entero Healthcare Solutions Ltd (NSE:ENTERO) has successfully reduced its net working capital days from 71 to 66 over the past year, with further reductions targeted by the end of the financial year.
- The company has expanded its network to serve over 71,000 retail pharmacies and more than 2,500 hospitals across 469 districts in India, supported by 102 strategically located warehouses.
- Despite higher gross margins, EBITDA margins slightly declined from 3.7% to 3.6% compared to the previous quarter due to annual salary and wage increases.
- Operating costs increased by 9% over the last quarter, outpacing the 5% revenue growth, impacting the operating leverage.
- The company faces challenges in quick-commerce for pharmaceuticals, with issues such as range limitations, low average order value, and prescription requirements.
- There is a dependency on external factors for the completion of acquisitions, which could delay revenue recognition from these deals.
- The company's tax rate for the quarter was low at 17%, which may not be sustainable in the long term without continued tax-efficient measures.
(Operator Instructions) Ladies and gentlemen, good day, and welcome to Q1 FY26 earnings conference call of Entero Healthcare Solutions Limited, hosted by Monarch Networth Capital Limited. (Operator Instructions) Please note that this conference is being recorded.
Please note this conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as on the date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict.
I now hand the conference over to Mr. Rahul Dani from Monarch Networth Capital. Thank you, and over to you.
Yes. Thank you. Hi. Good evening, everyone, and a very warm welcome to Entero Healthcare Solutions Q1 FY26 earnings call. On the call today, we have with us Mr. Prabhat Agarwal, Managing Director and CEO; and we have Mr. Balakrishnan Kaushik, Group CFO. I will hand over the call to the management for the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
